No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
IMVT250117P33000
- 0.00
- 0.000.00%
15min DelayClose Jan 3 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest33.00Strike Price0.00Turnover0.00%IV-33.01%PremiumJan 17, 2025Expiry Date8.19Intrinsic Value100Multiplier13DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma3.16Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Intraday
- 5D
- Daily
No Data
News
Wolfe Research Downgrades Immunovant(IMVT.US) to Hold Rating
Wolfe Research Downgrades Immunovant to Peer Perform From Outperform
We Think Immunovant (NASDAQ:IMVT) Can Afford To Drive Business Growth
Wells Fargo Maintains Immunovant(IMVT.US) With Buy Rating, Cuts Target Price to $45
Immunovant Is Maintained at Overweight by Wells Fargo
Immunovant Analyst Ratings